-+ 0.00%
-+ 0.00%
-+ 0.00%

ACLARIS THERAPEUTICS, INC. : WEDBUSH CUTS TO NEUTRAL FROM OUTPERFORM; CUTS TARGET PRICE TO $3 FROM $8

Reuters·11/17/2026 12:31:05